These results verified that ESM1 could promote metastasis and malignant progression of cervical cancer through ZEB1/EMT axis, ESM1 was an important regulatory gene in cervical cancer, thus, ESM1 could be a potential target for further drug screening. This evidence concerns the gene ZEB1 and cervical carcinoma.